SE7500501L - - Google Patents
Info
- Publication number
- SE7500501L SE7500501L SE7500501A SE7500501A SE7500501L SE 7500501 L SE7500501 L SE 7500501L SE 7500501 A SE7500501 A SE 7500501A SE 7500501 A SE7500501 A SE 7500501A SE 7500501 L SE7500501 L SE 7500501L
- Authority
- SE
- Sweden
- Prior art keywords
- dry powder
- bismuth
- jan
- powder
- gistbrocades
- Prior art date
Links
- 239000000843 powder Substances 0.000 abstract 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- 229910052797 bismuth Inorganic materials 0.000 abstract 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 abstract 1
- KKMOSYLWYLMHAL-UHFFFAOYSA-N 2-bromo-6-nitroaniline Chemical compound NC1=C(Br)C=CC=C1[N+]([O-])=O KKMOSYLWYLMHAL-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 abstract 1
- 102000057297 Pepsin A Human genes 0.000 abstract 1
- 108090000284 Pepsin A Proteins 0.000 abstract 1
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
- 229940069428 antacid Drugs 0.000 abstract 1
- 239000003159 antacid agent Substances 0.000 abstract 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 235000012730 carminic acid Nutrition 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000004040 coloring Methods 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229940111202 pepsin Drugs 0.000 abstract 1
- 208000011906 peptic ulcer disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 150000005846 sugar alcohols Polymers 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA00740385A ZA74385B (en) | 1974-01-18 | 1974-01-18 | Pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7500501L true SE7500501L (nl) | 1975-07-21 |
| SE437930B SE437930B (sv) | 1985-03-25 |
Family
ID=25567281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7500501A SE437930B (sv) | 1974-01-18 | 1975-01-17 | Forfarande for framstellning av en fast, vismuthaltig farmaceutisk komposition |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5837284B2 (nl) |
| AT (1) | AT349150B (nl) |
| AU (1) | AU485660B2 (nl) |
| BE (1) | BE824509A (nl) |
| CA (1) | CA1040532A (nl) |
| CH (1) | CH622947A5 (nl) |
| DE (1) | DE2501787A1 (nl) |
| DK (1) | DK151770C (nl) |
| ES (1) | ES433908A1 (nl) |
| FI (1) | FI750113A (nl) |
| FR (1) | FR2258177B1 (nl) |
| GB (1) | GB1478742A (nl) |
| IE (1) | IE40361B1 (nl) |
| IT (1) | IT1036072B (nl) |
| LU (1) | LU71668A1 (nl) |
| NL (1) | NL185130C (nl) |
| SE (1) | SE437930B (nl) |
| ZA (1) | ZA74385B (nl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
| US4801608A (en) * | 1981-09-22 | 1989-01-31 | Gist-Brocades N. V. | Bismuth containing composition and method for the preparation thereof |
| PH20649A (en) * | 1981-09-22 | 1987-03-16 | Gist Brocades Nv | Bismuth containing composition and method for the preparation thereof |
| EP0222834A4 (en) * | 1985-04-18 | 1989-10-04 | Borody Thomas J | TREATMENT OF NON-ULCERATIVE DYSPEPSIA WITH BISMUTOUS SALTS. |
| US4748113A (en) * | 1985-06-13 | 1988-05-31 | Marshall Barry J | Compositions and methods for the diagnosis of gastrointestinal disorders involving urease |
| US5256684A (en) * | 1985-06-13 | 1993-10-26 | The Procter & Gamble Company | Methods and compositions for the treatment of gastrointestinal disorders |
| EP0206627B1 (en) * | 1985-06-13 | 1992-08-12 | Barry James Dr. Marshall | Methods for the treatment of gastrointestinal disorders |
| ATE135582T1 (de) * | 1985-06-13 | 1996-04-15 | Barry James Marshall | Verfahren und zusammensetzungen zur behandlung von gastrointestinalen störungen |
| ES2040307T3 (es) * | 1988-10-08 | 1993-10-16 | Dr. R. Pfleger Chemische Fabrik Gmbh | Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto. |
| DE3901508C2 (de) * | 1989-01-19 | 1994-04-07 | Falk Pharma Gmbh | Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form |
| IT1229502B (it) * | 1989-01-25 | 1991-09-03 | Euroresearch Srl | Composizioni contenenti bismuto idonee per uso terapeutico. |
| IE893167A1 (en) * | 1989-10-04 | 1991-04-24 | Ulso Lab Ltd | Preparation of orally administrable liquids for use in¹therapy |
| US5843482A (en) * | 1990-07-20 | 1998-12-01 | Tillotts Pharma Ag | Products and processes for the treatment of the alimentary canal |
| US5192752A (en) * | 1991-01-14 | 1993-03-09 | The Procter & Gamble Company | Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate |
| US5834002A (en) | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
| US6902738B2 (en) | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
| US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
| US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
| US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
| MX9703918A (es) | 1997-05-28 | 1998-11-30 | J Marshall M D Barry | Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior. |
| US6998250B2 (en) | 2001-10-15 | 2006-02-14 | Donald J. McMichael | Method for detecting Helicobacter pylori |
| US7008777B2 (en) | 2001-10-15 | 2006-03-07 | Barry J. Marshall | System for the detection of urease and method for using same |
| USD484988S1 (en) | 2001-12-17 | 2004-01-06 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kit with specimen-handling tool |
| US6783976B2 (en) | 2001-12-21 | 2004-08-31 | Kimberly-Clark Worldwide, Inc. | Carrier and specimen-handling tool for use in diagnostic testing |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1963781A1 (de) * | 1968-12-23 | 1970-07-09 | Serfontein Willem Jacob | Verbesserte Wismuth-Praeparate |
| GB1259151A (en) * | 1968-12-23 | 1972-01-05 | Willem Jacob Serfontein | Bismuth complexes |
-
1974
- 1974-01-18 ZA ZA00740385A patent/ZA74385B/xx unknown
-
1975
- 1975-01-14 AU AU77293/75A patent/AU485660B2/en not_active Expired
- 1975-01-16 CH CH51075A patent/CH622947A5/de not_active IP Right Cessation
- 1975-01-16 JP JP50007408A patent/JPS5837284B2/ja not_active Expired
- 1975-01-17 LU LU71668A patent/LU71668A1/xx unknown
- 1975-01-17 SE SE7500501A patent/SE437930B/xx not_active IP Right Cessation
- 1975-01-17 FR FR7501521A patent/FR2258177B1/fr not_active Expired
- 1975-01-17 GB GB2146/75A patent/GB1478742A/en not_active Expired
- 1975-01-17 DE DE19752501787 patent/DE2501787A1/de active Granted
- 1975-01-17 AT AT31875A patent/AT349150B/de not_active IP Right Cessation
- 1975-01-17 ES ES433908A patent/ES433908A1/es not_active Expired
- 1975-01-17 BE BE152481A patent/BE824509A/xx not_active IP Right Cessation
- 1975-01-17 CA CA218,092A patent/CA1040532A/en not_active Expired
- 1975-01-17 DK DK012675A patent/DK151770C/da not_active IP Right Cessation
- 1975-01-17 NL NLAANVRAGE7500552,A patent/NL185130C/nl not_active IP Right Cessation
- 1975-01-17 IT IT67104/75A patent/IT1036072B/it active
- 1975-01-17 IE IE86/75A patent/IE40361B1/xx unknown
- 1975-01-17 FI FI750113A patent/FI750113A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE40361L (en) | 1975-07-18 |
| BE824509A (fr) | 1975-07-17 |
| FR2258177A1 (nl) | 1975-08-18 |
| CH622947A5 (en) | 1981-05-15 |
| DE2501787A1 (de) | 1975-07-24 |
| FI750113A (nl) | 1975-07-19 |
| ES433908A1 (es) | 1976-11-16 |
| SE437930B (sv) | 1985-03-25 |
| LU71668A1 (nl) | 1975-06-24 |
| FR2258177B1 (nl) | 1978-07-21 |
| ZA74385B (en) | 1975-08-27 |
| DK12675A (nl) | 1975-09-15 |
| AU7729375A (en) | 1976-07-15 |
| NL7500552A (nl) | 1975-07-22 |
| CA1040532A (en) | 1978-10-17 |
| ATA31875A (de) | 1978-08-15 |
| AU485660B2 (en) | 1977-07-28 |
| GB1478742A (en) | 1977-07-06 |
| DK151770B (da) | 1988-01-04 |
| JPS5837284B2 (ja) | 1983-08-15 |
| JPS50116623A (nl) | 1975-09-12 |
| NL185130B (nl) | 1989-09-01 |
| IE40361B1 (en) | 1979-05-09 |
| NL185130C (nl) | 1990-02-01 |
| DE2501787C2 (nl) | 1987-11-12 |
| IT1036072B (it) | 1979-10-30 |
| AT349150B (de) | 1979-03-26 |
| DK151770C (da) | 1989-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7500501L (nl) | ||
| GB1405088A (en) | Slow release formulation | |
| KR900700093A (ko) | 수용성 이부프로펜 제제 및 그 제조방법 | |
| GB1465347A (en) | Composition | |
| HK52380A (en) | Aqueous preparations of dyestuffs or optical brighteners insoluble to difficultly soluble in water as well as the use thereof | |
| GB1530106A (en) | Stannous pyrophosphate technetium-99m compositions | |
| GB1417003A (en) | Stabilisation of fibrinogen | |
| SE311208B (nl) | ||
| ES400927A1 (es) | Un procedimiento para preparar un dentifrico estable. | |
| GB1256968A (nl) | ||
| GB1274797A (en) | Effervescent tablets and powders | |
| IT1229502B (it) | Composizioni contenenti bismuto idonee per uso terapeutico. | |
| GB1486687A (en) | Iron-resin adsorbate | |
| GB1338071A (en) | Pharmaceutical iron preparations | |
| ES404959A1 (es) | Un procedimiento para preparar una composicion acuosa es- table de dexiciclina. | |
| JPS5492618A (en) | Poultice | |
| GB1221038A (en) | Improvements in effervescent tablet compositions | |
| GB1327560A (en) | Effervescent pharmaceutical preparations | |
| ES314805A1 (es) | Mejoras introducidas en la preparaciën de composiciones-efervescentes en forma de pastillas | |
| GB1449146A (en) | Prostaglandins and the preparation thereof | |
| JPS4814656B1 (nl) | ||
| GB524756A (en) | Medicinal preparations of magnesium hydroxide and precess of obtaining the same | |
| GB1504767A (en) | Antibiotic compositions | |
| GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
| GB1288892A (nl) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7500501-7 Effective date: 19940810 Format of ref document f/p: F |